Comparative Study Between Ultrasound Guided Paravertebral Plane Block and Erector Spinae Plane Block on Post-operative Analgesia After Total Abdominal Hysterectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-60
SponsorAin Shams University

About this trial

The intent of this study is to compare the efficacy of the erector spinae plane block (ESPB) and paravertebral plane block in reducing postoperative opioid consumption and pain in patients with total abdominal hysterectomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA I and ASA II patients.

Female, 30-60 years of age.

Scheduled for total abdominal hysterectomy.

Disqualifiers

Patient refusal of procedure or participation in the study.

Opioid or analgesic abuse.

Known allergy to study drug.

Local infection at the site of puncture.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Paravertebral Plane Block

    Procedure/Surgery

    The spinous process of the 10th thoracic vertebra will be located under the ultrasound guided (USG) linear probe. Under aseptic precautions, a 22-G short-beveled needle will be inserted under ultrasonographic guidance using the in-plane approach and was directed medially between the transverse process (TP) and the pleura. The needle will traverse the superior costotransverse ligament and enter the paravertebral space, where 2 ml of normal saline will be injected. The tip of the needle will be in the paravertebral space, noting the pleura being pushed down. Then, 20 ml of 0.25% bupivacaine will be injected into the paravertebral space under USG visualization.

  • Erector Spinea Plane Block

    Procedure/Surgery

    The USG linear probe will be placed Longitudinal 3 cm lateral to T10 transverse process TP. A 22-G short-beveled needle will be inserted in the cephalad to caudal direction through the erector spinae to contact the T10 TP using the in-plane technique. After the needle made contact with TP, the plane will be confirmed by injecting 2ml of saline and depositing 20ml of 0.25% bupivacaine.

  • bupivicaine 0.25%

    Drug

    20 ml of 0.25% bupivacaine will be injected

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Paravertebral Plane BlockActive comparator 2 interventions
Group B: Erector Spinea Plane BlockActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

total morphine consumption

Postoperative total morphine requirements in the first 24 hours after surgery.

Time frame
from the end of surgey to 24 hrs post operative

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: